Identifying inherited metabolic disorders in children: the role of elevated creatine kinase

Abstract Introduction Elevated creatine kinase (CK) levels are key indicators of muscle injury and are commonly used in the differential diagnosis of pediatric disorders, particularly inherited metabolic disorders (IMDs). However, variability in CK elevation and the absence of standardized diagnosti...

Full description

Saved in:
Bibliographic Details
Main Authors: Merve Yoldaş Çelik, Burcu Köşeci
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Pediatrics
Subjects:
Online Access:https://doi.org/10.1186/s12887-025-05953-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388811226710016
author Merve Yoldaş Çelik
Burcu Köşeci
author_facet Merve Yoldaş Çelik
Burcu Köşeci
author_sort Merve Yoldaş Çelik
collection DOAJ
description Abstract Introduction Elevated creatine kinase (CK) levels are key indicators of muscle injury and are commonly used in the differential diagnosis of pediatric disorders, particularly inherited metabolic disorders (IMDs). However, variability in CK elevation and the absence of standardized diagnostic thresholds complicate its clinical interpretation. This study aimed to evaluate the diagnostic utility of CK levels in distinguishing IMDs from other etiologies and to identify clinical and biochemical patterns that could facilitate earlier recognition of IMDs. Methods We retrospectively analyzed 1,660 pediatric patients seen at a metabolic clinic, identifying 320 (19.3%) who had CK measurements. Among them, 99 patients (30.9%) had elevated CK levels (> 171 U/L). These patients were divided into three diagnostic groups: idiopathic, IMD-diagnosed, and other diseases. “Idiopathic” referred to cases without a confirmed diagnosis. Biochemical parameters (CK, AST, LDH) were compared, and receiver operating characteristic (ROC) analysis was performed. Results Thirteen patients (15.1%) were diagnosed with IMDs. The IMD group showed significantly higher CK and AST levels compared to the idiopathic group (p < 0.05). ROC analysis indicated that a CK cut-off of 617.5 U/L had a sensitivity of 61.5% and specificity of 88.0% for identifying IMDs. However, CK alone could not effectively distinguish other diseases from idiopathic cases. Advanced metabolic investigations and comprehensive clinical evaluations were essential for accurate diagnosis. Conclusion While CK levels offer useful preliminary diagnostic information, they must be interpreted alongside advanced metabolic testing and clinical findings for reliable diagnosis. This study emphasizes the value of a multidisciplinary approach in assessing elevated CK levels in pediatric patients and calls for further research to optimize diagnostic pathways.
format Article
id doaj-art-8dd72fdb9d2d4ab5a8ea6f113a1f420f
institution Kabale University
issn 1471-2431
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series BMC Pediatrics
spelling doaj-art-8dd72fdb9d2d4ab5a8ea6f113a1f420f2025-08-20T03:42:10ZengBMCBMC Pediatrics1471-24312025-08-012511910.1186/s12887-025-05953-6Identifying inherited metabolic disorders in children: the role of elevated creatine kinaseMerve Yoldaş Çelik0Burcu Köşeci1Adana City Training and Research Hospital, Department of Pediatric Metabolism and NutritionAdana City Training and Research Hospital, Department of Pediatric Metabolism and NutritionAbstract Introduction Elevated creatine kinase (CK) levels are key indicators of muscle injury and are commonly used in the differential diagnosis of pediatric disorders, particularly inherited metabolic disorders (IMDs). However, variability in CK elevation and the absence of standardized diagnostic thresholds complicate its clinical interpretation. This study aimed to evaluate the diagnostic utility of CK levels in distinguishing IMDs from other etiologies and to identify clinical and biochemical patterns that could facilitate earlier recognition of IMDs. Methods We retrospectively analyzed 1,660 pediatric patients seen at a metabolic clinic, identifying 320 (19.3%) who had CK measurements. Among them, 99 patients (30.9%) had elevated CK levels (> 171 U/L). These patients were divided into three diagnostic groups: idiopathic, IMD-diagnosed, and other diseases. “Idiopathic” referred to cases without a confirmed diagnosis. Biochemical parameters (CK, AST, LDH) were compared, and receiver operating characteristic (ROC) analysis was performed. Results Thirteen patients (15.1%) were diagnosed with IMDs. The IMD group showed significantly higher CK and AST levels compared to the idiopathic group (p < 0.05). ROC analysis indicated that a CK cut-off of 617.5 U/L had a sensitivity of 61.5% and specificity of 88.0% for identifying IMDs. However, CK alone could not effectively distinguish other diseases from idiopathic cases. Advanced metabolic investigations and comprehensive clinical evaluations were essential for accurate diagnosis. Conclusion While CK levels offer useful preliminary diagnostic information, they must be interpreted alongside advanced metabolic testing and clinical findings for reliable diagnosis. This study emphasizes the value of a multidisciplinary approach in assessing elevated CK levels in pediatric patients and calls for further research to optimize diagnostic pathways.https://doi.org/10.1186/s12887-025-05953-6Creatine kinaseCKInherited metabolic disordersMetabolic myopathiesBiochemical markersMultisystem ınvolvement
spellingShingle Merve Yoldaş Çelik
Burcu Köşeci
Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
BMC Pediatrics
Creatine kinase
CK
Inherited metabolic disorders
Metabolic myopathies
Biochemical markers
Multisystem ınvolvement
title Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
title_full Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
title_fullStr Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
title_full_unstemmed Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
title_short Identifying inherited metabolic disorders in children: the role of elevated creatine kinase
title_sort identifying inherited metabolic disorders in children the role of elevated creatine kinase
topic Creatine kinase
CK
Inherited metabolic disorders
Metabolic myopathies
Biochemical markers
Multisystem ınvolvement
url https://doi.org/10.1186/s12887-025-05953-6
work_keys_str_mv AT merveyoldascelik identifyinginheritedmetabolicdisordersinchildrentheroleofelevatedcreatinekinase
AT burcukoseci identifyinginheritedmetabolicdisordersinchildrentheroleofelevatedcreatinekinase